185 related articles for article (PubMed ID: 23640101)
1. Novel naphthalimide polyamine derivatives as potential antitumor agents.
Seliga R; Pilatova M; Sarissky M; Viglasky V; Walko M; Mojzis J
Mol Biol Rep; 2013 Jun; 40(6):4129-37. PubMed ID: 23640101
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of naphthalimide-polyamine conjugates modified by alkylation as anticancer agents through p53 pathway.
Dai F; He H; Xu X; Chen S; Wang C; Feng C; Tian Z; Dong H; Xie S
Bioorg Chem; 2018 Apr; 77():16-24. PubMed ID: 29316508
[TBL] [Abstract][Full Text] [Related]
3. Novel chiral naphthalimide-cycloalkanediamine conjugates: Design, synthesis and antitumor activity.
Costales P; Ríos-Lombardía N; Lorenzo-Herrero S; Morís F; González-Sabín J
Bioorg Chem; 2021 Jul; 112():104859. PubMed ID: 33836453
[TBL] [Abstract][Full Text] [Related]
4. A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent.
Ma J; Li L; Yue K; Zhang Z; Su S; Chen Y; Yu L; Zhang P; Ma R; Li Y; Ma Y; Jia H; Wang C; Wang J; Xie S
Eur J Med Chem; 2021 Oct; 221():113469. PubMed ID: 33965862
[TBL] [Abstract][Full Text] [Related]
5. Novel bisnaphthalimidopropyl (BNIPs) derivatives as anticancer compounds targeting DNA in human breast cancer cells.
Kopsida M; Barron GA; Bermano G; Kong Thoo Lin P; Goua M
Org Biomol Chem; 2016 Oct; 14(41):9780-9789. PubMed ID: 27722499
[TBL] [Abstract][Full Text] [Related]
6. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
Wu A; Xu Y; Qian X
Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of naphthalimide-carborane and metallacarborane conjugates: Anticancer activity, DNA binding ability.
Nekvinda J; Różycka D; Rykowski S; Wyszko E; Fedoruk-Wyszomirska A; Gurda D; Orlicka-Płocka M; Giel-Pietraszuk M; Kiliszek A; Rypniewski W; Bachorz R; Wojcieszak J; Grüner B; Olejniczak AB
Bioorg Chem; 2020 Jan; 94():103432. PubMed ID: 31776032
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Activity and Topoisomerase II Inhibition of Naphthalimides with ω-Hydroxylalkylamine Side-Chains of Different Lengths.
Tomczyk MD; Byczek-Wyrostek A; Strama K; Wawszków M; Kasprzycki P; Walczak KZ
Med Chem; 2019; 15(5):550-560. PubMed ID: 30207241
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of substituted naphthalimides to polyamines as cytotoxic agents targeting the Akt/mTOR signal pathway.
Tian ZY; Xie SQ; Mei ZH; Zhao J; Gao WY; Wang CJ
Org Biomol Chem; 2009 Nov; 7(22):4651-60. PubMed ID: 19865701
[TBL] [Abstract][Full Text] [Related]
10. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
Wu A; Xu Y; Qian X; Wang J; Liu J
Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, electrochemistry, DNA binding and in vitro cytotoxic activity of tripodal ferrocenyl bis-naphthalimide derivatives.
Fan YR; Wang BJ; Jia DG; Yang XB; Huang Y
J Inorg Biochem; 2021 Jun; 219():111425. PubMed ID: 33831713
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of naphthalimide-benzimidazole conjugates as potential antitumor agents.
Singh I; Luxami V; Paul K
Org Biomol Chem; 2019 May; 17(21):5349-5366. PubMed ID: 31099353
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and in vitro cytotoxicity of naphthalimide polyamine conjugates as antitumor agents].
Mei ZH; Tian ZY; Ma HX; Xie SQ; Zhao J; Wang CJ
Yao Xue Xue Bao; 2009 Jul; 44(7):754-7. PubMed ID: 19806915
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, DNA Binding, and Anticancer Properties of Bis-Naphthalimide Derivatives with Lysine-Modified Polyamine Linkers.
Huang Y; Wu CX; Song Y; Huang M; Tian DN; Yang XB; Fan YR
Molecules; 2018 Jan; 23(2):. PubMed ID: 29382135
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy.
Rioux B; Pinon A; Gamond A; Martin F; Laurent A; Champavier Y; Barette C; Liagre B; Fagnère C; Sol V; Pouget C
Eur J Med Chem; 2021 Oct; 222():113586. PubMed ID: 34116328
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives.
Li S; Xu S; Tang Y; Ding S; Zhang J; Wang S; Zhou G; Zhou C; Li X
Bioorg Med Chem Lett; 2014 Jan; 24(2):586-90. PubMed ID: 24370011
[TBL] [Abstract][Full Text] [Related]
17. Lysosomes-targeting imaging and anticancer properties of novel bis-naphthalimide derivatives.
Rong RX; Wang SS; Liu X; Li RF; Wang KR; Cao ZR; Li XL
Bioorg Med Chem Lett; 2018 Feb; 28(4):742-747. PubMed ID: 29342415
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel amonafide-polyamine conjugates as anticancer agents.
Wang Y; Zhang J; Li M; Li M; Xie S; Wang C
Chem Biol Drug Des; 2017 May; 89(5):670-680. PubMed ID: 27762101
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Evaluation of Novel 3-Carboranyl-1,8-Naphthalimide Derivatives as Potential Anticancer Agents.
Rykowski S; Gurda-Woźna D; Orlicka-Płocka M; Fedoruk-Wyszomirska A; Giel-Pietraszuk M; Wyszko E; Kowalczyk A; Stączek P; Bak A; Kiliszek A; Rypniewski W; Olejniczak AB
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803403
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.
Liang GB; Wei JH; Jiang H; Huang RZ; Qin JT; Wang HL; Wang HS; Zhang Y
Eur J Med Chem; 2021 Jan; 210():112951. PubMed ID: 33109400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]